SML3515

Bulevirtide trifluoroacetate

≥98% (HPLC)

• Synonym(e): Myrcludex B trifluoroacetate, Myrcludex-B trifluoroacetate, N-Tetradecanoylglycyl-Thr-Asn-Leu-Ser-Val-Pro-Asn-Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro-Asn-Lys-Asp-His-Trp-Pro-Glu-Ala-Asn-Lys-Val-Gly-NH2 trifluoroacetate
• Empirische Formel (Hill-System): C₂₄₈H₃₅₅N₆₅O₇₂ · xC₂HF₃O₂
• Molekulargewicht: 5398.86 (free base basis)
• NACRES: NA.77
• UNSPSC Code: 12352200
• Assay: ≥98% (HPLC)
• Form: (Powder or Lyophilized powder or film)
• Storage condition: desiccated

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: (Powder or Lyophilized powder or film)
• storage condition: desiccated
• color: white to off-white
• storage temp.: -10 to -25°C

Beschreibung

Biochem/physiol Actions

Bulevirtide is a synthetic lipopeptide derived from the preS1 domain of the Hepatitis B virus (HBV) envelope protein that specifically binds to hepatocytes and efficiently blocks de novo HBV and its satellite virus hepatitis D (HDV) infection both in vitro and in vivo.

HDV and HBV virion entry inhibitor

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable